# AI-Augmented Diagnostic Assessment With ENLIGHT Versus Independent Pathologist Review

> **NCT07741058** · NA · ENROLLING_BY_INVITATION · sponsor: **Harvard Medical School (HMS and HSDM)** · enrollment: 25 (estimated)

## Conditions studied

- Cancer

## Interventions

- **BEHAVIORAL:** Unaided Review First, Then AI as Double-Check, Then AI as First-Look.
- **BEHAVIORAL:** Unaided Review First, Then AI as First-Look, Then AI as Double-Check.
- **BEHAVIORAL:** AI as Double-Check First, Then AI as First-Look, Then Unaided Review.
- **BEHAVIORAL:** AI as First-Look First, Then AI as Double-Check, Then Unaided Review.

## Key facts

- **NCT ID:** NCT07741058
- **Lead sponsor:** Harvard Medical School (HMS and HSDM)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-07
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2026-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07741058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07741058, "AI-Augmented Diagnostic Assessment With ENLIGHT Versus Independent Pathologist Review". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07741058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*